New York State Common Retirement Fund Iterum Therapeutics PLC Transaction History

New York State Common Retirement Fund

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$1.19 - $4.38 $21,717 - $79,935	-18,250 Closed	0 $0
Q1 2020 May 06, 2020	BUY	$1.55 - $4.56 $387 - $1,140	250 Added 1.39%	18,250 $49,000
Q3 2019 Nov 07, 2019	BUY	$5.77 - $7.65 $12,174 - $16,141	2,110 Added 13.28%	18,000 $104,000
Q2 2019 Aug 09, 2019	SELL	$6.09 - $9.1 $3,045 - $4,550	-500 Reduced 3.05%	15,890 $109,000
Q1 2019 May 08, 2019	SELL	$4.88 - $8.17 $4,928 - $8,251	-1,010 Reduced 5.8%	16,390 $132,000
Q4 2018 Feb 08, 2019	SELL	$5.01 - $7.9 $3,757 - $5,925	-750 Reduced 4.13%	17,400 $87,000
Q2 2018 Aug 10, 2018	BUY	$10.67 - $12.85 $193,660 - $233,227	18,150 New	18,150 $198,000

Ticker ITRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,233,400
Market Cap $15.9M
Description
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract inf...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.